Myron Schwartz
Icahn School of Medicine at Mount Sinai
H-index: 103
North America-United States
Top articles of Myron Schwartz
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response | Alimentary Pharmacology & Therapeutics | Jung Eun Park Vy H Nguyen Pei‐Chien Tsai Hidenori Toyoda Jennifer Leong | 2024/1/3 |
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma | Josep M Llovet Roser Pinyol Mark Yarchoan Amit G Singal Thomas U Marron | 2024/2/29 | |
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis | Annals of Surgical Oncology | Matthew L Holzner Vincenzo Mazzaferro Michele Droz Dit Busset Luca Aldrighetti Francesca Ratti | 2024/2/9 |
Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy | European Radiology | Daniel Stocker Michael J King Maria El Homsi Jeffrey Gnerre Brett Marinelli | 2024/1 |
Improved Outcomes of Liver Resection for Hepatitis C-related Hepatocellular Carcinoma After the Introduction of Direct-Acting Antiviral Therapy | HPB | Chiara Rocha Joseph Di Norcia Parissa Tabrizian Chiara Di Renzo Salvatore Amodeo | 2024/4/30 |
Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors | BJC Reports | Y Linda Wu Sarah Cappuyns Amanda Loh Sean Sun Sara Lewis | 2024/1/29 |
Immunotherapy and Transplantation for Hepatocellular Carcinoma | Parissa Tabrizian Maen Abdelrahim Myron Schwartz | 2024/1/20 | |
48 Analyzing Changing Trends in Hepatocellular Carcinoma | Journal of Clinical and Translational Science | Adriana Pero Keith Sigel Myron Schwartz | 2024/4 |
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus–and Hepatitis C Virus–Related Hepatocellular Carcinoma | Journal of Clinical Oncology | Daniel Q Huang Joseph K Hoang Rubayet Kamal Pei-Chien Tsai Hidenori Toyoda | 2024/1/4 |
Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma | British Journal of Surgery | Zhong-Qi Fan Matteo Serenari Xing Lv Myron Schwartz Wei Qiu | 2024/3 |
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development | Immunity | Xiaochen Wang Qifeng He Chuanli Zhou Yueyuan Xu Danhui Liu | 2023/1/10 |
816 RACIAL AND ETHNIC DISPARITIES IN DIRECT-ACTING ANTIVIRAL (DAA) TREATMENT AND SURVIVAL OUTCOMES FOR TREATED/SVR (SUSTAINED VIROLOGIC RESPONSE) AND UNTREATED/NON-SVR PATIENTS … | Gastroenterology | Jung Eun Park Vy H Nguyen Pei-Chien Tsai Hidenori Toyoda Jennifer Leong | 2023/5/1 |
Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study | Gastroenterology | K Rajender Reddy Dale McLerran Tracey Marsh Neehar Parikh Lewis R Roberts | 2023/10/1 |
Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma | Gastroenterology | Philipp K Haber Florian Castet Miguel Torres-Martin Carmen Andreu-Oller Marc Puigvehí | 2023/1/1 |
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis | Cancer Medicine | Chiara Rocha Erin H Doyle Chip A Bowman M‐Isabel Fiel Ashley E Stueck | 2023/5 |
Semiautomated segmentation of hepatocellular carcinoma tumors with MRI using convolutional neural networks | European Radiology | Daniela Said Guillermo Carbonell Daniel Stocker Stefanie Hectors Naik Vietti-Violi | 2023/9 |
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification | Gut | Carla Montironi Florian Castet Philipp K Haber Roser Pinyol Miguel Torres-Martin | 2023/1/1 |
Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapse-free survival (RFS) in hepatocellular carcinoma (HCC) patients treated with perioperative … | Cancer Research | Thomas U Marron Laura Brennan Pauline Hamon Maria Isabel Fiel Stephen C Ward | 2023/4/4 |
LBA4 Low-dose stereotactic body radiotherapy prior to pre-operative cemiplimab for patients with resectable hepatocellular carcinoma | Immuno-Oncology and Technology | TU Marron O Hapanowicz N Lucas K Wu M Buckstein | 2023/12/1 |
Metabolomic liquid biopsy dynamics predict early onset of human hepatocarcinogenesis | Zeitschrift für Gastroenterologie | Kornelius Schulze Tim Daniel Rose Lorenz Adlung Manuela Peschka Thorben W Fründt | 2023/8 |
